Summary
- Current Price
- As of today, MRK price is $147.24, down -1.76% on
- Current Price All-Time High
- MRK price is currently -6.17% below its historical high of $156.92 set on
- Market Cap
- MRK current market cap is $363B, up +66.70% over the past 365 days
- PE Ratio
- MRK current PE ratio is 117.69
- Revenue
- MRK current annual revenue is $64.93B, up +1.49% year-over-year
- Next Earnings
- The next earnings release for MRK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Merck & Co., Inc. |
| Ticker | NYSE: MRK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | merck.com |
| Employees | 73,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $147.24 | |
| Price, 1D Change | -1.76% | |
| Market Cap | $363B | |
| TTM Dividend Yield | 2.31% | |
| PE Ratio | 117.69 | |
| Beta | 0.14 | |
| Revenue | $64.93B | |
| Revenue, 1Y Change | +1.49% | |
| EPS | $7.28 | |
| EPS, 1Y Change | +8.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.85 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 131:125 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $7.28 | |
| EPS Estimate | $2.66 | N/A |
| EPS Est. Change | -63.51% | N/A |
| Revenue | $64.93B | |
| Revenue Estimate | $67.04B | N/A |
| Revenue Est. Change | +3.25% | N/A |
| Current Price | $147.24 | |
| Price Target | $163.00 | - |
| Price Tgt. Change | +10.70% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.62 | $6.74 | -11.61% | |
| $8.94 | $7.28 | -18.52% | |
| $2.66 | N/A | -63.51% | |
| $9.29 | N/A | +27.61% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $64.00B | $63.97B | -0.04% | |
| $64.80B | $64.93B | +0.20% | |
| $67.04B | N/A | +3.25% | |
| $69.93B | N/A | +7.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +68.06% | |
| Price, 3Y | +43.41% | |
| Market Cap, 1Y | +66.70% | |
| Market Cap, 3Y | +39.56% | |
| Revenue, 1Y | +1.49% | |
| Revenue, 3Y | +11.04% | |
| EPS, 1Y | +8.09% | |
| EPS, 3Y | +27.48% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $147.24 | |
| SMA 200 | $125.68 | |
| SMA 50 | $146.45 | |
| EMA 200 | $126.86 | |
| EMA 50 | $143.39 | |
| MACD | $0.56 | |
| Beta | 0.14 | |
| ATR | $4.36 | |
| 14-Day RSI | 52.91 | |
| 10-Day Volatility | 35.00% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.85 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.23% | |
| Total Dividend | $3.28 | |
| Dividends Paid | $8.18B | |
| Payout Ratio | 44.77% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $64.93B | |
| EPS | $7.28 | |
| Gross Profit | $52.98B | |
| Gross Margin | 81.50% | |
| Operating Income | $26.78B | |
| Operating Margin | 41.19% | |
| Net Income | $18.26B | |
| Net Margin | 28.09% | |
| EBITDA | $29.32B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.96 | |
| Current Ratio | 1.54 | |
| Quick Ratio | 1.30 | |
| - | ||
| Piotroski F-Score | 5 | |
| Altman Z-Score | 4.59 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $52.61B | |
| Cash & Equivalents | $14.69B | |
| Total Assets | $136.87B | |
| Current Assets | $43.52B | |
| Total Liabilities | $84.20B | |
| Current Liabilities | $28.33B | |
| Total Debt | $50.53B | |
| Short Term Debt | $2.88B | |
| Accounts Payable | $4.40B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $46.76B | |
| Operating Expenses | $26.21B | |
| Cost Of Goods Sold | $12.03B | |
| SG&A | $0.00 | |
| D&A | $5.84B | |
| Interest Expense | $0.00 | |
| Income Tax | $2.80B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $16.47B | |
| CFI | -$13.74B | |
| CFF | -$1.92B | |
| Capex | $4.11B | |
| Free Cash Flow | $12.36B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Citigroup | → | |
| Cantor Fitzgerald | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Scotiabank | → | |
| HSBC | → | |
| Leerink Partners | → | |
| Guggenheim | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with MRK
FAQ
- What is the ticker symbol for Merck & Co., Inc.?
- The ticker symbol for Merck & Co., Inc. is NYSE:MRK
- Does Merck & Co., Inc. pay dividends?
- Yes, Merck & Co., Inc. pays dividends. The last payment was $0.85, with an ex-dividend date on September 15, 2026
- What sector is Merck & Co., Inc. in?
- Merck & Co., Inc. is in the Healthcare sector
- What industry is Merck & Co., Inc. in?
- Merck & Co., Inc. is in the General Drug Manufacturers industry
- What country is Merck & Co., Inc. based in?
- Merck & Co., Inc. is headquartered in United States
- When did Merck & Co., Inc. go public?
- Merck & Co., Inc. initial public offering (IPO) was on January 13, 1978
- Is Merck & Co., Inc. in the S&P 500?
- Yes, Merck & Co., Inc. is included in the S&P 500 index
- Is Merck & Co., Inc. in the NASDAQ 100?
- No, Merck & Co., Inc. is not included in the NASDAQ 100 index
- Is Merck & Co., Inc. in the Dow Jones?
- Yes, Merck & Co., Inc. is included in the Dow Jones index
- When was Merck & Co., Inc. last earnings report?
- Merck & Co., Inc.'s most recent earnings report was on August 4, 2026
- When does Merck & Co., Inc. report earnings?
- The next expected earnings date for Merck & Co., Inc. is October 29, 2026
Data Sources & References
- MRK Official Website www.merck.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- MRK Profile on Yahoo Finance finance.yahoo.com/quote/MRK
- MRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrk
